BCRT response to Moller

Affiliations

¹ Department of Genomic Medicine, Manchester Academic Health Science Centre, Central Manchester Foundation Trust, St. Mary's Hospital, Manchester University, Oxford Road, M13 9WL, Manchester, UK, gareth.evans@cmft.nhs.uk.

Comment

D Gareth Evans. Breast Cancer Res Treat. 2014 Dec.

. 2014 Dec;148(3):693.

doi: 10.1007/s10549-014-3200-7.

¹ Department of Genomic Medicine, Manchester Academic Health Science Centre, Central Manchester Foundation Trust, St. Mary's Hospital, Manchester University, Oxford Road, M13 9WL, Manchester, UK, gareth.evans@cmft.nhs.uk.

No abstract available

Comment on

MRI breast screening in high-risk women: cancer detection and survival analysis.
Evans DG, Kesavan N, Lim Y, Gadde S, Hurley E, Massat NJ, Maxwell AJ, Ingham S, Eeles R, Leach MO; MARIBS Group; Howell A, Duffy SW. Evans DG, et al. Breast Cancer Res Treat. 2014 Jun;145(3):663-72. doi: 10.1007/s10549-014-2931-9. Epub 2014 Apr 1. Breast Cancer Res Treat. 2014. PMID: 24687378
MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis.
Tharmaratnam K, Hagen AI, Møller P. Tharmaratnam K, et al. Breast Cancer Res Treat. 2014 Dec;148(3):687-8. doi: 10.1007/s10549-014-3178-1. Epub 2014 Nov 15. Breast Cancer Res Treat. 2014. PMID: 25398653 Free PMC article. No abstract available.